EU and US could reach trade deal this weekend - Reuters
Investing.com - UBS upgraded IMCD NV (AS:IMCD) to Neutral from Sell on Monday, while slightly lowering its price target to EUR122.00 from EUR128.00.
The upgrade comes as IMCD shares have fallen approximately 20% year-to-date, pushing the stock to trade at its historic trough multiple, according to UBS.
The investment bank noted that while it maintains concerns about an earnings "reset" in chemical distribution, it believes the current valuation of approximately 13.5x FY2026 estimated EV/EBITA now appropriately reflects these pressures.
UBS has further reduced its earnings outlook for IMCD to account for deteriorating volume and gross profit per unit expected over Q2-Q3 2025, with new adjusted EBITA forecasts 2-6% below consensus for fiscal years 2025-2026.
The chemical distributor faces ongoing challenges in the sector, with UBS specifically highlighting recent profit warnings from other companies in the industry as adding to short-term risks.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.